The introduction of weight loss drugs, such as Ozempic and semaglutide, is expected to have indirect effects on various industries and sectors. These drugs not only help people lose weight but also impact the economy by changing consumer behavior and preferences. Patients using these drugs have shown a decrease in appetite, leading to changes in their consumption patterns. For instance, customers buying these medications spent less on food but more on lifestyle and fitness. The use of weight loss drugs could also lead to improved productivity, as individuals experience better health outcomes and longer, happier lives. These drugs have the potential to bring about significant benefits to individuals, businesses, and the overall economy.
| Signal | Change | 10y horizon | Driving force |
|---|---|---|---|
| New weight loss drugs impact economy | Impact on consumption and productivity | Shift towards healthier products | Desire for better health and increased productivity |
| GLP-1 drugs changing consumer behavior | Shift in spending habits | Decrease in fast-food, restaurants, coffee shops | Health-consciousness and desire for weight loss |
| Weight loss leads to indirect benefits | Changes in fuel consumption and addiction treatment | Potential cost savings for airlines and reduced spending on addictive substances | Improved health outcomes and potential cost savings |
| Longer, healthier lives increase productivity | Increase in productivity and personal happiness | Reduced sick days, increased self-esteem | Improved health and well-being |
| Government funding for weight loss drugs | Potential coverage and accessibility | Increased availability and affordability | Comparison to public health crises like COVID-19 |